Digital Therapeutics For Fibromyalgia Market Report 2026

Digital Therapeutics For Fibromyalgia Market Overview

• Digital Therapeutics For Fibromyalgia market size has reached to $1.19 billion in 2025 • Expected to grow to $3.07 billion in 2030 at a compound annual growth rate (CAGR) of 20.8% • Growth Driver: The Growing Awareness Of Digital Health Solutions Is Fueling The Growth Of The Market Due To Government-Backed Promotion And Widespread Adoption Of Official Health Apps • Market Trend: Prescription-Based Digital Therapeutics And Remote Monitoring For Enhanced Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Digital Therapeutics For Fibromyalgia Market?

Digital therapeutics for fibromyalgia are health apps and online programs that deliver structured therapy and track symptoms to support day-to-day self-management. Its purpose is to ease pain and fatigue, improve sleep and function, and give patients and clinicians useful data to personalize care. The main product types of digital therapeutics for fibromyalgia are software applications, devices, and platforms. Software applications refer to clinically validated programs designed to provide therapeutic interventions for managing fibromyalgia symptoms, including pain and fatigue. These solutions are distributed through online and offline channels. Key applications include chronic pain management, sleep disorders, fatigue management, and others, with primary end users being hospitals, clinics, homecare, and others.

What Is The Digital Therapeutics For Fibromyalgia Market Growth Forecast?

The digital therapeutics for fibromyalgia market size is expected to see exponential growth in the next few years. It will grow to $3.07 billion in 2030 at a compound annual growth rate (CAGR) of 20.8%. The growth in the forecast period can be attributed to increasing demand for personalized chronic pain management, rising integration of ai-driven therapy optimization, expansion of remote care reimbursement models, growing focus on data-driven treatment personalization, increasing collaboration between clinicians and digital health providers. Major trends in the forecast period include increasing adoption of symptom-tracking mobile therapies, rising use of personalized digital care plans, growing integration of wearables with therapeutic platforms, expansion of remote patient monitoring programs, enhanced focus on patient engagement and adherence.

Global Digital Therapeutics For Fibromyalgia Market Segmentation

1) By Product Type: Software Applications, Devices, Platforms 2) By Therapy Area: Cognitive Behavioral Therapy, Mindfulness-Based Interventions, Pain Management, Other Therapy Types 3) By Distribution Channel: Online, Offline 4) By Application: Chronic Pain Management, Sleep Disorders, Fatigue Management, Other Applications 5) By End-User: Hospitals, Clinics, Homecare, Other End-Users Subsegments: 1) By Software Applications: Mobile Applications, Web-Based Applications, Cloud-Based Applications, Virtual Reality Applications 2) By Devices: Wearable Devices, Handheld Devices, Smart Monitoring Devices, Connected Therapeutics Devices 3) By Platforms: Telehealth Platforms, Remote Monitoring Platforms, Patient Engagement Platforms, Data Analytics Platforms

What Is The Driver Of The Digital Therapeutics For Fibromyalgia Market?

The growing awareness of digital health solutions are expected to propel the growth of the digital therapeutics for fibromyalgia market going forward. Digital health solutions are software-enabled tools and services such as patient apps, patient portals, and virtual-care platforms that deliver information, monitoring, and therapy through digital channels. The increasing awareness of digital health solutions is due to government-backed promotion and widespread adoption of official health apps that normalize online access to care. Digital therapeutics for fibromyalgia leverage this awareness by meeting patients in those familiar channels, streamlining onboarding and adherence to app-based cognitive behavioral therapy, pacing, and sleep programs while enabling clinician oversight. For instance, in December 2023, according to the National Health Service, a UK-based government department, digital health app users reached 33.6 million, up from 16.8 million in 2022, with monthly logins rising 54% from 16.8 million to 25.8 million. Therefore, the growing awareness of digital health solutions is driving the digital therapeutics for fibromyalgia industry.

Key Players In The Global Digital Therapeutics For Fibromyalgia Market

Major companies operating in the digital therapeutics for fibromyalgia market are Grünenthal GmbH, Hinge Health Inc., DarioHealth Corp., Kaia Health, CogniFit Inc., Big Health Ltd., Remedee Labs, HelloBetter GmbH, AppliedVR Inc., PainDrainer, Swing Therapeutics Inc., Fern Health Inc., JOGO Health Inc., LIN Health Inc., MoreGoodDays, Happify Health Inc., Click Therapeutics Inc., Wellthy Therapeutics Pvt. Ltd., FlexifyMe, SleepioRx

Global Digital Therapeutics For Fibromyalgia Market Trends and Insights

Major companies operating in the digital therapeutics for fibromyalgia market are focusing on technological advancements such as computerized behavioral therapy devices to deliver evidence-based interventions that improve pain management, reduce fatigue, enhance sleep quality, and support mental health, all through scalable, patient-centric digital platforms. A computerized behavioral therapy device refers to a software-based digital platform or application that delivers structured, evidence-based cognitive or behavioral therapy interventions to patients remotely, often using interactive modules, exercises, and real-time feedback to manage symptoms of conditions such as fibromyalgia. For instance, in May 2023, Swing Therapeutics, Inc., a US-based biopharmaceutical company, launched Stanza following U.S. FDA De Novo marketing authorization (DEN220083). It delivers a 12-week, self-guided acceptance and commitment therapy (ACT) program for fibromyalgia, with a randomized controlled trial in the lancet reporting significant clinical improvements. This is delivered via smartphone (iOS or Android), and meets patients in-app for convenient, at-home therapy.

What Are Latest Mergers And Acquisitions In The Digital Therapeutics For Fibromyalgia Market?

In February 2025, XRHealth Inc., a US-based therapeutic extended reality (XR) and digital-therapeutics company, acquired RealizedCare for an undisclosed amount. With this acquisition, XRHealth aims to integrate RealizedCare’s immersive digital-therapeutics content and artificial intelligence triage tool into its platform to broaden evidence-based care for chronic pain and behavioral health, including XRHealth’s existing fibromyalgia programs, while scaling artificial intelligence-enabled, value-based delivery and strengthening clinician oversight and personalization. RealizedCare is a US-based immersive digital-therapeutics company focused on chronic pain and behavioral health.

Regional Insights

North America was the largest region in the digital therapeutics for fibromyalgia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Digital Therapeutics For Fibromyalgia Market?

The digital therapeutics for fibromyalgia market consists of revenues earned by entities by providing services such as remote health coaching and therapist support, tele-physiotherapy consultations, adherence and engagement services, and outcomes analytics and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital therapeutics for fibromyalgia market also includes sales of cognitive behavioral therapy (cbt) apps, pain neuroscience education modules, digital graded exercise and activity pacing programs, virtual reality-based pain distraction experiences, and sleep hygiene and relaxation programs, clinician dashboards and care coordination tools, patient. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Digital Therapeutics For Fibromyalgia Market Report 2026?

The digital therapeutics for fibromyalgia market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the digital therapeutics for fibromyalgia industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.